Table 2.

Frequency of cancers and autoantibodies^*

	Stanford University (n = 111)	Johns Hopkins University (n = 102)	Total (n = 213)
Cancer	17 (15.3)	12 (11.8)	29 (13.6)
Anti–NXP-2
With cancer	5	4	9
Without cancer	10	18	28
Total	15 (13.5)	22 (21.6)	37 (17.4)
Anti–TIF-1γ
With cancer	8	7	15
Without cancer	34	33	67
Total	42 (37.8)	40 (39.2)	82 (38.4)
Other autoantibodies
With cancer	4†	1†	5‡
Without cancer	51	40	91
Total	55 (49.5)	41 (40.2)	96 (45.1)

^*Values are the number or number (%) of patients. There were no significant differences between the cohorts. Anti–TIF-1γ = anti–transcription intermediary factor 1γ.

^†P < 0.05 versus no cancer.

^‡P < 0.005 versus no cancer.